Andrew Bomback

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. ncbi A piece of my mind. Errands
    Andrew Bomback
    JAMA 295:731-3. 2006
  2. pmc Rituximab therapy for membranous nephropathy: a systematic review
    Andrew S Bomback
    Department of Medicine, Division of Nephrology and Hypertension, University of North Carolina Kidney Center, Chapel Hill, North Carolina 27599 7155, USA
    Clin J Am Soc Nephrol 4:734-44. 2009
  3. pmc Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review
    Andrew S Bomback
    UNC Kidney Center, Department of Medicine, Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7155, USA
    Am J Nephrol 30:140-6. 2009
  4. ncbi Jack London's "chronic interstitial nephritis". A historical differential diagnosis
    Andrew S Bomback
    Department of Medicine, Division of Nephrology and Hypertension, University of North Carolina School of Medicine, Chapel Hill, USA
    Pharos Alpha Omega Alpha Honor Med Soc 71:26-30. 2008
  5. ncbi Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review
    Andrew S Bomback
    Department of Medicine, Division of Nephrology and Hypertension, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Am J Kidney Dis 51:199-211. 2008
  6. ncbi The incidence and implications of aldosterone breakthrough
    Andrew S Bomback
    University of North Carolina Kidney Center, Chapel Hill, NC 27599 7155, USA
    Nat Clin Pract Nephrol 3:486-92. 2007
  7. ncbi Of snakes and men: the evolution of ACE inhibitors
    Andrew S Bomback
    Department of Medicine, University of North Carolina School of Medicine, Kidney Center, Chapel Hill, North Carolina, 27599 7155, USA
    J Renin Angiotensin Aldosterone Syst 8:1-2. 2007
  8. doi Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination
    Andrew S Bomback
    Department of Medicine, Division of Nephrology, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Am J Hypertens 22:1032-40. 2009
  9. doi Racial differences in kidney function among individuals with obesity and metabolic syndrome: results from the Kidney Early Evaluation Program (KEEP)
    Andrew S Bomback
    Department of Medicine, Division of Nephrology, Columbia University College of Physicians and Surgeons, 622 W 168th Street, New York, NY 10032, USA
    Am J Kidney Dis 55:S4-S14. 2010
  10. ncbi The Kidney Education Outreach Program's community-based screenings: participants' demographics and screening results
    Donna H Harward
    UNC Kidney Center, USA
    N C Med J 70:507-12. 2009

Detail Information

Publications20

  1. ncbi A piece of my mind. Errands
    Andrew Bomback
    JAMA 295:731-3. 2006
  2. pmc Rituximab therapy for membranous nephropathy: a systematic review
    Andrew S Bomback
    Department of Medicine, Division of Nephrology and Hypertension, University of North Carolina Kidney Center, Chapel Hill, North Carolina 27599 7155, USA
    Clin J Am Soc Nephrol 4:734-44. 2009
    ..The treatment of membranous nephropathy (MN) remains controversial. Rituximab, which selectively targets B cells, has emerged as a possible alternative treatment option with limited toxicity...
  3. pmc Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review
    Andrew S Bomback
    UNC Kidney Center, Department of Medicine, Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7155, USA
    Am J Nephrol 30:140-6. 2009
    ....
  4. ncbi Jack London's "chronic interstitial nephritis". A historical differential diagnosis
    Andrew S Bomback
    Department of Medicine, Division of Nephrology and Hypertension, University of North Carolina School of Medicine, Chapel Hill, USA
    Pharos Alpha Omega Alpha Honor Med Soc 71:26-30. 2008
  5. ncbi Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review
    Andrew S Bomback
    Department of Medicine, Division of Nephrology and Hypertension, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Am J Kidney Dis 51:199-211. 2008
    ....
  6. ncbi The incidence and implications of aldosterone breakthrough
    Andrew S Bomback
    University of North Carolina Kidney Center, Chapel Hill, NC 27599 7155, USA
    Nat Clin Pract Nephrol 3:486-92. 2007
    ....
  7. ncbi Of snakes and men: the evolution of ACE inhibitors
    Andrew S Bomback
    Department of Medicine, University of North Carolina School of Medicine, Kidney Center, Chapel Hill, North Carolina, 27599 7155, USA
    J Renin Angiotensin Aldosterone Syst 8:1-2. 2007
  8. doi Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination
    Andrew S Bomback
    Department of Medicine, Division of Nephrology, Columbia University College of Physicians and Surgeons, New York, New York, USA
    Am J Hypertens 22:1032-40. 2009
    ..This review examines what is presently known about ACEI/ARB combination therapy and explores alternative combination strategies that include DRIs and mineralocorticoid receptor blockers (MRBs)...
  9. doi Racial differences in kidney function among individuals with obesity and metabolic syndrome: results from the Kidney Early Evaluation Program (KEEP)
    Andrew S Bomback
    Department of Medicine, Division of Nephrology, Columbia University College of Physicians and Surgeons, 622 W 168th Street, New York, NY 10032, USA
    Am J Kidney Dis 55:S4-S14. 2010
    ....
  10. ncbi The Kidney Education Outreach Program's community-based screenings: participants' demographics and screening results
    Donna H Harward
    UNC Kidney Center, USA
    N C Med J 70:507-12. 2009
    ....
  11. pmc A hypertension risk score for middle-aged and older adults
    Abhijit V Kshirsagar
    Department of Medicine, UNC Kidney Center and Division of Nephrology and Hypertension, School of Medicine, Chapel Hill, NC 27599, USA
    J Clin Hypertens (Greenwich) 12:800-8. 2010
    ..75-0.78) in the testing sample at 3, 6, and 9 years of follow-up. This risk calculator may aide health care providers in guiding discussions with patients about the risk for progression to hypertension...
  12. doi Extracellular volume and aldosterone interaction in chronic kidney disease
    Philip J Klemmer
    UNC Kidney Center, University of North Carolina Chapel Hill, Chapel Hill, N C, USA
    Blood Purif 27:92-8. 2009
    ..This combination may lead to cardiovascular and renal inflammation and fibrosis that can be mitigated by more precise control of ECV and/or blockade of the mineralocorticoid receptor...
  13. pmc A simple algorithm to predict incident kidney disease
    Abhijit V Kshirsagar
    Division of Nephrology and Hypertension, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7155, USA
    Arch Intern Med 168:2466-73. 2008
    ..Despite the growing burden of chronic kidney disease (CKD), there are no algorithms (to our knowledge) to quantify the effect of concurrent risk factors on the development of incident disease...
  14. ncbi Jack London's "mysterious malady"
    Andrew S Bomback
    Division of Nephrology and Hypertension, University of North Carolina School of Medicine, Chapel Hill, USA
    Am J Med 120:466-7. 2007
  15. pmc Sugar-sweetened beverage consumption and the progression of chronic kidney disease in the Multi-Ethnic Study of Atherosclerosis (MESA)
    Andrew S Bomback
    Department of Medicine, Division of Nephrology, Columbia University Medical Center, New York, NY 10032, USA
    Am J Clin Nutr 90:1172-8. 2009
    ....
  16. ncbi The physical exam and the sense of smell
    Andrew Bomback
    University of North Carolina Hospitals, Chapel Hill, USA
    N Engl J Med 354:327-9. 2006
  17. pmc Disordered aldosterone-volume relationship in end-stage kidney disease
    Andrew S Bomback
    Columbia University College of Physicians and Surgeons, Department of Medicine, Division of Nephrology, New York, NY, USA
    J Renin Angiotensin Aldosterone Syst 10:230-6. 2009
    ..Sodium loading, and subsequent volume expansion, suppresses aldosterone levels in individuals with normal renal function. We hypothesised that loss of renal function impairs this volume-aldosterone relationship...
  18. pmc Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004)
    Abhijit V Kshirsagar
    Division of Nephrology and Hypertension, School of Medicine, University of North Carolina, University of North Carolina Kidney Center, Chapel Hill, North Carolina, USA
    Am J Cardiol 101:401-6. 2008
    ..In conclusion, elevated CRP levels were associated with microalbuminuria in a large, nationally representative data set. Vascular inflammation, as measured by CRP, may be a common contributor to early heart and kidney disease...
  19. pmc Sugar-sweetened soda consumption, hyperuricemia, and kidney disease
    Andrew S Bomback
    Division of Nephrology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA
    Kidney Int 77:609-16. 2010
    ..Thus our study shows that high consumption of sugar-sweetened soda was associated with prevalent but not incident hyperuricemia and chronic kidney disease...
  20. ncbi Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population: a reply
    Andrew S Bomback
    Nephrol Dial Transplant 22:1787-8; author reply 1788. 2007